Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens

Full text
Author(s):
Perez-Riverol, Amilcar [1] ; Justo-Jacomini, Debora Lais [1] ; Zollner, Ricardo de Lima [2] ; Brochetto-Braga, Marcia Regina [1, 3]
Total Authors: 4
Affiliation:
[1] UNESP Univ Estadual Paulista, LBMA IB RC, BR-13506900 Rio Claro, SP - Brazil
[2] Univ Estadual Campinas, FCM, Dept Clin Med, LIAE, BR-13083887 Campinas, SP - Brazil
[3] Univ Estadual Paulista, CEVAP, BR-18610307 Botucatu, SP - Brazil
Total Affiliations: 3
Document type: Review article
Source: TOXINS; v. 7, n. 7, p. 2551-2570, JUL 2015.
Web of Science Citations: 13
Abstract

Along with food and drug allergic reactions, a Hymenoptera insect Sting (Apoidea, Vespidae, Formicidae) is one of the most common causes of anaphylaxis worldwide. Diagnoses of Hymenoptera venom allergy (HVA) and specific immunotherapy (SIT) have been based on the use of crude venom extracts. However, the incidence of cross-reactivity and low levels of sensibility during diagnosis, as well as the occurrence of nonspecific sensitization and undesired side effects during SIT, encourage the search for novel allergenic materials. Recombinant allergens are an interesting approach to improve allergy diagnosis and SIT because they circumvent major problems associated with the use of crude venom. Production of recombinant allergens depends on the profound molecular characterization of the natural counterpart by combining some omics approaches with high-throughput screening techniques and the selection of an appropriate system for heterologous expression. To date, several clinically relevant allergens and novel venom toxins have been identified, cloned and characterized, enabling a better understanding of the whole allergenic and envenoming processes. Here, we review recent findings on identification, molecular characterization and recombinant expression of Hymenoptera venom allergens and on the evaluation of these heterologous proteins as valuable tools for tackling remaining pitfalls on HVA diagnosis and immunotherapy. (AU)

FAPESP's process: 14/13936-7 - Allergens from venom of the social wasp Polybia paulista (Hymenoptera, Vespidae): recombinant expression in yeast for improved diagnosis and specific immunotherapy to Hymenoptera venom allergy
Grantee:Márcia Regina Brochetto Braga
Support Opportunities: Regular Research Grants